The Korean Biopharma Industry and Market Overview in New York Pharma Forum

The New York Pharma Forum will present Korean biophama industry and market overview in June 30 2009. The New York Pharma Forum provides a vehicle for dialogue among U.S and Japanese biopharmaceutical executives and business and financial professionals on global issues of common interest. The New York Pharma Forum chose Korean biopharma market issue this time based on growing interest for Korean biopharma market.

New York, NY (PRWEB) June 27, 2009 -- The New York Pharma Forum will present Korean biophama industry and market overview in June 30 2009. The New York Pharma Forum provides a vehicle for dialogue among U.S and Japanese biopharmaceutical executives and business and financial professionals on global issues of common interest. The New York Pharma Forum chose Korean biopharma market issue this time based on growing interest for Korean biopharma market.

With a population approaching 50 million and overall GDP estimated at $1.278 trillion in 2008, South Korea ranks as one of the world's leading economies today. The country ranks 11th in the global pharmaceutical market by size, and the market is expected to grow to $15.6 billion by 2013. South Korea has approximately 570 pharmaceutical manufacturers. Korean government injects around one billion dollars over ten years to boost the Korean pharmaceutical industry, with over 80 percent of the total earmarked for R&D. Korea has made dramatic advances recently in clinical trials as well.

This program will feature presentations by experts representing the Korean biopharmaceutical industry who will provide a comprehensive overview of the country's healthcare system, biopharma industry, and business opportunities. Speakers will provide a wide range of information from therapeutic markets to profiles of the major players, regulatory and policy related issues, and intellectual property rights.

In addition, KHIDI (Korea Health Industry Development Institute) which is Korean Ministry of Health agency will hand out a directory book of Korean major pharmaceutical companies. The directory book includes the list of 100 major players of Korea with their amount of sales, revenue, major therapeutic area, and contact information. Directory book also contains teaser memorandum(TM)s of 27 state-of-the-art biotechnologies which are available to be licensed out.

The New York Pharma Forum featuring Korean biophama industry overview will be held at the Nippon Club located in 145 West 57th Street New York City. To attend the forum, visit www.nypharmaforum.org.

###